Werner syndrome (WS) is a rare autosomalrecessive disorder characterized by the premature appearance of features of normal aging in young adults. The extensive phenotypic overlap between WS and normal aging suggests they may also share pathogenetic mechanisms. We reported previously that somatic cells from WS patients demonstrate a
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propensity to develop chromosomal aberrations, including translocations, inversions, and deletions, and that WS cell lines demonstrate a high spontaneous mutation rate to 6-thioguanine resistance. We report here the biochemical and molecular characterization of spontaneous mutations at the X chromosome-linked hypoxanthine phosphoribosyltransferase (HPRT) locus in 6-thioguanine-resistant WS and control cells. Blot hybridization analysis of 89 independent spontaneous HPRT mutations in WS and control mutants lacking HPRT activity revealed an unusually high proportion of HPRT deletions in WS as compared with control cells (76% vs. 39%). Approximately half (58%) of the deletions in WS cells consisted of the loss of greater than 20 kilobases of DNA from the HPRT gene. These results suggest that an elevated somatic mutation rate, and particularly deletions, may play pathogenetically important roles in WS and in several associated age-dependent human disease processes.
Werner syndrome (WS; McKusick catalog no. 27770) is a rare autosomal-recessive human disorder characterized by the premature appearance in young adults of several features of normal aging (1) (2) (3) . The extensive phenotypic overlap between WS and normal aging suggests that they may share pathogenetic mechanisms as well. This possibility has been explored by comparing the properties of cells and tissues from WS patients with those derived from control donors (3, 4) . For example, skin fibroblast cells derived from WS patients demonstrate a severely limited capacity to divide in vitro. The limited in vitro division potential of WS fibroblasts is similar to, though more extreme than, that displayed by fibroblasts from aged normal donors (4).
We have reported two lines of evidence that suggest somatic mutations may play a role in the pathogenesis of WS and of associated age-dependent disease processes: somatic cells from WS patients display a propensity to develop chromosomal translocations, inversions, and deletions; and simian virus 40 (SV40)-transformed fibroblast cell lines from unrelated WS patients display an elevated spontaneous mutation rate at the X chromosome-linked hypoxanthine phosphoribosyltransferase (HPRT; EC 2.4.2.8) locus (5, 6) .
We report here the biochemical and molecular characterization of 89 independent spontaneous HPRT mutations in 6-thioguanine (Sgu)-resistant mutants isolated from two WS and two control SV40-transformed fibroblast cell lines. These results confirm our previous identification (6) (7) and from an unrelated 29-year-old female WS patient (cell line PSV811) (8) . Control SV40-transformed fibroblast cell lines derived from an 8-year-old male with galactosemia (cell line GM639) and from a normal 18-year-old female (cell line GM637) were obtained from the National Institute of General Medical Sciences Human Genetic Mutant Cell Repository (Camden, NJ). All four cell lines were grown in Dulbecco's modified Eagle's medium supplemented with 6% (vol/vol) fetal bovine serum (GIBCO, Grand Island, NY, or Biologos, Naperville, IL), penicillin (100 units/ml), and streptomycin (100 gg/ml) in a humidified atmosphere of 5% C02/95% air, at 370C. Cell lines were tested on several occasions using a 4',6-diamidino-2-phenylindole (DAPI) fluorescence assay and found to be negative for the presence of mycoplasma.
Determination of Spontaneous Mutation Rates. The spontaneous mutation rates of WS and control cells to Sgu resistance were determined by the fluctuation test of Luria and Delbruck (9) , as described (6), and by the serial sampling method of Newcombe (10, 11) . In mutation rate determinations by the method of Newcombe (10, 11) , replicate cultures that contained no Sgu-resistant colonies in an initial portion plated in Sgu (i.e., initial mutation frequency, F1 = 0) were replated after 6-7 weeks of additional cell growth to determine the frequency of Sgu-resistant colonies (final mutation frequency, F2). Independent Sgu-resistant mutants isolated during mutation rate determinations in the presence of 60 AM Sgu were subsequently grown for biochemical and molecular analysis.
Biochemical and Molecular Characterization of HPRT Mutations. HPRT activity in Sgu-resistant WS and control cells was measured by the method of Bakay et al. (12) as described (13) . The parent cell lines and a Lesch-Nyhan lymphoblastoid cell line (GM2292A) (14) were used as positive and negative controls for HPRT enzyme activity assays.
Isolation and blot hybridization analysis of nuclear DNA and RNA from Sgu-resistant WS and control cells using a human HPRT cDNA probe were performed as described (13) . Localization of deletions within the HPRT gene and the identification of exons contained in novel-sized restriction fragments derived from the X chromosome-linked HPRT locus were performed with probes consisting of a 5' portion of the first HPRT intron (pl.7; ref. 15 ) and subclones of a 908-base-pair HPRT cDNA probe (16) *To whom reprint requests should be addressed. 5 .4 x 10-9 9.2 x 10-9 Sgur, Sgu resistant. *Mutant colony frequencies for each cell line were corrected by dividing by colony-forming efficiency for the mutation rate calculations. The spontaneous mutation rate, a, was calculated using the following formula (11): a = (In 2) (F2)/ln(N2/N1). tMean number of Sgu-resistant colonies per replicate culture, r, was corrected by the cloning efficiency of the cell line used and by the ratio of the number of cells plated to the final cell number in each replicate. A total of 116 replicate cultures in all were used. The mutation rate, a, was calculated from the following formula of Luria and Delbruck (9): r = aN, ln(NtCa), where C is the number of replicate cultures used and Nt is the final cell number per replicate. exons 1, 3, 6, 7 plus 8 or exon 9. A 700-base-pair chicken f3-actin cDNA was used as a positive control probe in Northern blot analyses.
RESULTS
Spontaneous mutation rates to Sgu resistance ranged from 2.8 x 10-7 to 1.1 x 10-6 per cell per generation for the WS cell lines W-V and PSV811 and from 5.4 x 10-9 to 2.8 x 10-8 per cell per generation for the control cell lines GM637 and GM639 (Table 1) . Both WS and control cell lines were comparably sensitive to Sgu. Plateau survival frequencies were reached for each cell line at Sgu concentrations between 12 and 30 A.M (data not shown), and 56 of 57 independent Sgu-resistant sublines isolated in 60 A.M Sgu contained less than 1% of control HPRT activity (see Fig. 2 ). The HPRT activity assay used can detect 0.5% of control (wild type) HPRT activity (data not shown).
The structure of the HPRT gene in 66 independent Sguresistant WS and 23 independent Sgu-resistant control sublines was analyzed by Southern blot hybridization with a human HPRT cDNA probe (Figs. 1 and 2 (27/ 50 WS or 5/9 control sublines) of the HPRT gene. A restriction site polymorphism consisting of the loss of the EcoRI site in HPRT intron 5 was also identified in the parent W-V WS cell line and in Sgu-resistant W-V sublines (data not shown). Southern blot hybridization results were unambiguously interpretable in Sgu-resistant sublines isolated from the male-derived WS (W-V) and control (GM639) cell lines and from the female-derived PSV811 cell line, in which Sgu-resistant sublines appear to contain a single X chromosome. Only 1 of 6 Sgu-resistant sublines isolated from the female-derived control cell line GM637 contained an identifiable alteration in the HPRT gene (Fig. 1, GM637-27R) .
Northern blot hybridization analysis of steady-state HPRT mRNA levels in Sgu-resistant WS and control sublines revealed three patterns of hybridization (summarized in Fig. 2 (13, 14) . Sublines WV-32R2 and GM639-16R demonstrate complete deletion of the X chromosome-linked HPRT gene with loss of all X chromosome-linked exon-containing fragments.
Sublines WV-34R2 and PSV811-44R1 demonstrate loss of one X chromosome-linked exon-containing fragment each, whereas sublines GM637-27R and PSV811-46R1 demonstrate partial deletions of the HPRT gene with the appearance of additional fragments of 1.85 kb (GM637-27R) and 7.7 kb (PSV811-46R1). The 1.85-kb novel band identified in subline GM637-27R was produced by a deletion in the region of HPRT between exons 2 and 3 from the genetically active X chromosome in the female-derived GM637 cell line. The expected 2.5-kb exon 2-and 1.4-kb exon 3-containing Pst I fragments from the genetically inactive X chromosome in subline GM637-27R can be seen as bands of half intensity. The presence of the 3.2-kb exon 1-containing fragment in sublines (as shown on the left) was confirmed on blots washed at a slightly lower stringency (as shown on the right). A human HPRT cDNA probe (16) iLS-1 6 Werner Syndrome TG-resistant subline(s) HPRT mRNA. The blot hybridization assay used can detect 1% of control HPRT mRNA levels (data not shown).
DISCUSSION
Our results demonstrate that cell lines derived from unrelated WS patients have an elevated spontaneous mutation rate at the HPRT locus and that a high proportion of spontaneous HPRT mutations in Sgu-resistant WS cell lines consists of HPRT gene deletions. The mutation rates of WS and control cell lines were determined by two methods. Both methods demonstrated a greater than 10-fold elevation in the rate of forward mutation at the HPRT locus in WS cells (Table 1) . These results confirm, using two additional control cell lines, the previous identification (6) of a mutator phenotype in WS cells. We would suggest caution in interpreting the absolute mutation rate differences between WS and control cells, however, due to inherent difficulties in determining mutation rates in mammalian cells (17) and the small number of Sgu-resistant cells recovered from control cell lines (Table 1) .
The most surprising finding of the blot hybridization analysis of HPRT mutations in Sgu-resistant WS and control cells was the high proportion of deletions in WS cells (Fig. 2) . Fifty of 66 (or 76%) independent WS mutants demonstrated a partial or complete deletion of the HPRT gene. Only half as many deletions were observed in control cultures (9 of 23 mutants or 39%). This difference in the proportion of deletions is statistically significant (P < 0.0025, x2 = 8.67 with 1 degree offreedom in a single-tail test) and may be greater than the observed 2-fold difference for at least two reasons. The stringent selection conditions we used (60 ,uM Sgu) will select against HPRT mutants that contain residual HPRT activity. Mutants containing residual HPRT activity are likely to represent a larger fraction of mutants in control cultures, and thus their loss during selection would lead to an overestimate of the proportion of remaining deletions in control cultures. Second, the blot hybridization assays we used will not detect most microdeletions (<100 bp) in the 45-kb human HPRT gene (18) (19) (20) . If microdeletions are present in greater proportion in WS as compared with control cells, we would not have detected this difference.
The WS mutator phenotype appears to have a strong specificity for deletions. This preference suggests at least two mutational pathways that may be responsible for the WS mutator phenotype and the production of HPRT deletions in WS cells. WS cells could promote recombination between DNA sequences within and between chromosomes to produce deletions, inversions, and transpositions. Alternatively, WS cells might mimic the effects of x-and y-irradiation by producing high endogenous levels of reactive oxygen intermediates (21) . This intriguing possibility is suggested by the high proportion of deletions seen in collections of x-and y-ray-induced HPRT mutations (21) (22) (23) (24) . X-and y-radiation can also induce cytogenetic changes that occur spontaneously at high frequency in WS cells (5, 25) and the premature appearance of selected features of aging (26) .
One concern in using SV40-transformed WS cell lines to further investigate the WS mutator phenotype is that SV40 transformation alone or in concert with the WS mutation might alter cellular mutagenic pathways. SV40 transformation has been shown in selected instances to induce sisterchromatid exchanges and mutations and to increase protein translational error rates (27) (28) (29) (30) . It is unlikely that SV40 transformation alone is contributing to mutagenesis in the control cell lines we used: the observed mutation rates in control cells were quite low, and the mutational spectrum of control cells was similar to spontaneous HPRT mutational spectra determined using other human cell lines that were not derived by SV40 transformation (13, 31, 32 ). It will be necessary to determine the rate and spectrum of spontaneous HPRT mutations in primary WS cells to rule out the formal possibility that SV40 transformation and the WS mutation interact to alter mutagenesis in WS cells.
Two lines of evidence suggest that the mutator phenotype we observed using SV4O-transformed WS cell lines also occurs in WS patients. We have demonstrated translocation mosaicism in vitro in fibroblasts and lymphocytes from different WS patients and in primary fibroblast cultures derived from one WS patient (33) . In addition, an 8-fold elevation in the frequency of Sgu-resistant peripheral blood lymphocytes in five unrelated WS patients as compared with controls has been demonstrated using an autoradiographic assay (unpublished data, and ref. 34 ). The molecular analysis of spontaneous HPRT mutations in independent T-cell clones will be required to determine whether deletions are the predominant class of mutation in these cells.
The elevated rate and altered spectrum ofHPRT mutations we observed in WS cells suggest that somatic mutations, and perhaps the preferential accumulation of deletions, may play a role in the pathogenesis of WS and of associated agedependent human disease processes, such as neoplasia and atherosclerosis (35) (36) (37) . Deletions could initiate or promote these processes by altering the structure or expression of genes or the structure and mitotic transmission fidelity of chromosomes.
The mutator phenotype of WS and the limited cell division potential of WS cells in vitro may represent useful targets for gene transfer to complement, and thus identify, the genetic defect in WS. In addition, the detection of consistent deletions or chromosomal mutations in WS cells might allow genes that interact with the WS mutation to be identified. The identification and molecular characterization of the WS locus and of genes that interact with it may be of practical importance: these genes appear to modulate the rate of appearance of aging and of several clinically important age-associated human disease processes.
